fbpx

News & Press


FDA Grants Alkermes Orphan Drug Designation for the Treatment of Mucosal Melanoma

March 11, 2021

WASHINGTON, DC – The U.S. Food and Drug Administration (FDA) has recently granted orphan drug designation for the treatment of mucosal melanoma to Alkermes’ investigational engineered interleukin-2 (IL-2) variant immunotherapy, nemvaleukin alfa (“nemva …



#EyeGetDilated: Alton Pace in Memory of Daryl Pace

February 26, 2021

Guest blog from Alton Pace in memory of his half-sister Daryl who passed away from ocular melanoma: “Take care of your eyeballs!” This is what my sister Daryl would often say to me years before her ocular melanoma (OM) diagnosis. Being a teenager at th …



A Focus on Rare Melanoma Subtypes

February 26, 2021

Guest blog post from Mark Weinzierl, MRF board member and ocular melanoma survivor: My name is Mark Weinzierl and I am currently a board member of the Melanoma Research Foundation (MRF), the largest independent organization devoted to melanoma. My inte …



#OutOfTheShadows: Eileen Walther

February 26, 2021

Guest blog post from Eileen Walther, a mucosal melanoma survivor and avid beekeeper:  Early on, I knew I’d have choices to make. I get to pick how I want to live my life and I’ve always made a conscious choice to embrace joy and gratitude. In 2017 I re …



MRF 25th Anniversary: Improving Melanoma Screening Education for Primary Care Providers Serving Patients of Skin of Color

February 26, 2021

For our 25th anniversary, we share a guest blog from Samantha Black, an MD Candidate from UT Southwestern Medical School and an MRF grant recipient, on her grant entitled “Improving Melanoma Screening Education for Primary Care Providers Serving Patien …